AbbVie Inc. stays a Strong Buy after a Q4 2025 earnings beat led by HUMIRA, plus growth in immunology and neuroscience. Click ...

The data on Pfizer's GLP-1 offer early evidence that the injection can be administered less frequently than existing drugs ...

With training and planning, self-injecting your rheumatoid arthritis medication may be easier than you think.

Dr. Dan Thomson shares essential tips for injections, needle selection and syringe maintenance to ensure herd health and carcass quality.

AbbVie stock falls 3.6% despite Q4 earnings beat of $2.71/share and 2026 guidance topping estimates as oncology and aesthetics revenue decline.

The pharmaceutical sector mainstay has built an impressive and resilient portfolio. Fears of serious declines in the fundamentals following the loss of patent exclusivity for Humira were overblown.

Learn how to administer self-injecting biologic medications with these simple and effective tips. If topical medications haven’t been strong enough to control your psoriasis, your dermatologist may ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Prompt injection attacks can manipulate AI behavior in ways that traditional cybersecurity ...